Patent · US Active

Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases

US10385054B2 · kind B2 · utility

0Cited by

32References

19Claims

0Family size

Assignee

Janssen Sciences Ireland Unlimited Company · IE

Inventors

David Craig McGowan · Vilvoorde, BE
Serge Maria Aloysius Pieters · Wichelen, BE
Stefaan Julien Last · Lint, BE
Werner Constant Johan Embrechts · Beerse, BE
Tim Hugo Maria Jonckers · Heist-op-den-Berg, BE
Pierre Jean-Marie Bernard Raboisson · Sligo, IE

Key dates

Filing date	Jun 26, 2014
Grant date	Aug 20, 2019
Priority date	—
Expiry date	Jun 26, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention concerns pyrrolo[3,2-d]pyrimidine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treatment and/or therapy of diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.